JPH09309807A - Production of mixture of 3-isothiazolone and composition containing the same - Google Patents

Production of mixture of 3-isothiazolone and composition containing the same

Info

Publication number
JPH09309807A
JPH09309807A JP8344180A JP34418096A JPH09309807A JP H09309807 A JPH09309807 A JP H09309807A JP 8344180 A JP8344180 A JP 8344180A JP 34418096 A JP34418096 A JP 34418096A JP H09309807 A JPH09309807 A JP H09309807A
Authority
JP
Japan
Prior art keywords
methyl
mixture
structural formula
isothiazolin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8344180A
Other languages
Japanese (ja)
Other versions
JP3022365B2 (en
Inventor
Jin-Man Kim
金眞萬
Jin-Soo Lim
林眞洙
Seung-Hwan Kim
金承煥
Soon-Jong Hahn
韓淳宗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SENKIYOU INDASUTORI KK
SK Discovery Co Ltd
Original Assignee
SENKIYOU INDASUTORI KK
Sunkyung Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19442354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH09309807(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SENKIYOU INDASUTORI KK, Sunkyung Industries Ltd filed Critical SENKIYOU INDASUTORI KK
Publication of JPH09309807A publication Critical patent/JPH09309807A/en
Application granted granted Critical
Publication of JP3022365B2 publication Critical patent/JP3022365B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3526Organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3544Organic compounds containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition containing a less amount of impurities harmful to human bodies, safe and useful for various products as a microbe- killing agent by formulating a specific component. SOLUTION: This mixture of 3-isothiazolone is obtained by mixing a biologically effective dose of a component A which is a mixture of 2-methyl-4- isothiazoline-3-one expressed by formula I with 5-chloro-2-methyl-4-isothiazoline-3- one expressed by formula II, a component B which is an effective dose of a metal nitrate stabilizer and a sufficient amount of water to dissolve the components A and B. In this case, 4, 5-dichloro-2-methyl-4-isothiazoline-3-one, which is an impurity, is preferably contaminated in <20ppm based on 15,000ppm of the component A. A chromaticity of the obtained composition is preferably <=50.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、不純物として4,
5−ジクロロ−2−メチル−4−イソチアゾリン−3−
オンおよびニトロサミンまたはその誘導体を含有しない
安定化された3−イソチアゾロン混合物の製造方法およ
びかかる混合物を有効成分として含む安定化されたイソ
チアゾロン組成物に関する。
TECHNICAL FIELD The present invention relates to impurities as 4,
5-dichloro-2-methyl-4-isothiazoline-3-
The present invention relates to a method for producing a stabilized 3-isothiazolone mixture containing no on and nitrosamine or a derivative thereof, and a stabilized isothiazolone composition containing such a mixture as an active ingredient.

【0002】[0002]

【従来の技術】次の構造式(J )の2−メチル−4−イ
ソチアゾリン−3−オンと次の構造式(K )の5−クロ
ロ−2−メチル−4−イソチアゾリン−3−オンとの混
合物は安定性および持続性のある殺微生物剤としてよく
知られている。
2. Description of the Related Art A 2-methyl-4-isothiazolin-3-one of the following structural formula (J) and a 5-chloro-2-methyl-4-isothiazolin-3-one of the following structural formula (K) Mixtures are well known as stable and persistent microbicides.

【0003】[0003]

【化5】 Embedded image

【0004】したがって、かかるイソチアゾロン混合物
を有効成分として含有する組成物は、塗料、化粧品、界
面活性剤、農薬、食品などの各種製品に防腐剤として広
く使用されている。
Therefore, a composition containing such an isothiazolone mixture as an active ingredient is widely used as a preservative in various products such as paints, cosmetics, surfactants, agricultural chemicals and foods.

【0005】前記イソチアゾロン化合物は混用される場
合に相互間の相乗効果によってより強力な活性を示す
が、該混合物の活性度は構成化合物らの混合割合によっ
て変わる。前記構造式(J )の化合物に比べて前記構造
式(K )の化合物が高い割合で含まれている場合生理活
性が増大すると知られている。したがって、有効な化合
物(J )および化合物(K )の混合物を製造する改善さ
れた方法を開発するための多くの研究が行われてきた。
大部分の従来の製造方法は、前記混合物の製造工程で二
硫化物を出発物質として用いる時必然的に生成されるニ
トロサミン前駆体の生成を効果的に調節、または除去す
ることに焦点を置いている。
When the isothiazolone compounds are used together, they exhibit stronger activity due to the synergistic effect between them, but the activity of the mixture varies depending on the mixing ratio of the constituent compounds. It is known that the physiological activity is increased when the compound of the structural formula (K) is contained at a higher ratio than the compound of the structural formula (J). Therefore, much work has been done to develop improved processes for making effective compound (J) and compound (K) mixtures.
Most conventional manufacturing methods focus on effectively controlling or eliminating the formation of the nitrosamine precursor that is inevitably formed when using disulfide as a starting material in the manufacturing process of said mixture. There is.

【0006】しかし、従来の方法に製造された化合物
(J )と化合物(K )との混合物は非活性成分として次
の構造式(L )の4,5−ジクロロ−2−メチル−4−
イソチアゾリン−3−オンを含有する。
However, a mixture of the compound (J) and the compound (K) produced by the conventional method is used as an inactive component and has the following structural formula (L) of 4,5-dichloro-2-methyl-4-.
Contains isothiazolin-3-one.

【0007】[0007]

【化6】 [Chemical 6]

【0008】次の反応図式1は、ヨーロッパ特許第9
5、907号に開示されている化合物(J )と化合物
(K )との混合物の製造方法を示す。
The following reaction scheme 1 is described in European Patent No. 9
A method for producing a mixture of the compound (J) and the compound (K) disclosed in 5,907 is shown.

【0009】[0009]

【化7】 [Chemical 7]

【0010】前記反応図式1では、構造式(C)の二硫
化物を構造式(D)のメチルアミンでアミド化させて構
造式(A−2)のN,N′−ジメチル−3,3′−ジチ
オジプロピオンアミドを得、これを塩素化剤、例えば、
塩素を用いて塩素化/環化反応させて目的する化合物
(J )と化合物(K )の混合物を製造する。
In Reaction Scheme 1, the disulfide of structural formula (C) is amidated with methylamine of structural formula (D) to form N, N'-dimethyl-3,3 of structural formula (A-2). ′ -Dithiodipropionamide is obtained, which is a chlorinating agent, eg
A mixture of the target compound (J) and compound (K) is produced by performing a chlorination / cyclization reaction using chlorine.

【0011】しかし、前記反応図式1に示した反応工程
は皮膚刺激物質としてよく知られている前記構造式(L
)のジクロロ化合物を相当量生成する。さらに、動物
実験結果によると、前記化合物(L )によって一時的に
刺激を受けた動物は有効活性成分である前記構造式(K
)の5−クロロ化合物によっても皮膚刺激が起こると
報告されている(文献[Bruze et al.,D
ermatosen 5,165−168(198
7)]参照)。
However, the reaction process shown in the reaction scheme 1 is the structural formula (L
The dichloro compound of 1) is produced in a considerable amount. Furthermore, according to the results of animal experiments, animals temporarily stimulated by the compound (L) have the structural formula (K
It has been reported that the 5-chloro compound also causes skin irritation (Reference [Bruze et al., D
ermatosen 5,165-168 (198
7)])).

【0012】一方、米国特許第5,068,338号
は、化合物(J )と化合物(K )との混合物の製造工程
で、次の反応図式2のように、反応副産物として次の構
造式(F)のN−メチル−3−(N−メチルアミノ)ア
ミノプロピオンアミドが生成することを報告した。
On the other hand, US Pat. No. 5,068,338 is a process for producing a mixture of a compound (J) and a compound (K), and the following structural formula ( It was reported that F) of N-methyl-3- (N-methylamino) aminopropionamide was produced.

【0013】[0013]

【化8】 Embedded image

【0014】前記反応図式で、構造式(A−2)の化合
物が分解して形成された構造式(E)のN−メチルアク
リルアミドは構造式(D)のメチルアミンと1,4−付
加反応して構造式(F)のN−メチル−3−(N−メチ
ルアミノ)アミノプロピオンアミドを生成する。構造式
(F)の化合物はニトロサミン前駆体であり、構造式
(E)のN−メチルアクリルアミドとさらに反応してま
た他のニトロサミン前駆体を生成することもできる。
In the above reaction scheme, the N-methylacrylamide of the structural formula (E) formed by decomposing the compound of the structural formula (A-2) is the 1,4-addition reaction with the methylamine of the structural formula (D). To produce N-methyl-3- (N-methylamino) aminopropionamide of structural formula (F). The compound of structural formula (F) is a nitrosamine precursor and can be further reacted with N-methylacrylamide of structural formula (E) to produce other nitrosamine precursors.

【0015】前記米国特許5、068、338号はま
た、構造式(F)のニトロサミン前駆体が化合物(J )
と化合物(K )との混合物に続けて残留して、次の反応
図式3のように、安定化剤として添加する硝酸塩(NO
x)とニトロソ化反応を起こして次の構造式(B)のN
−メチル−3−(N−ニトロソ)アミノプロピオンアミ
ドが生成し得ると記述している。
The above-mentioned US Pat. No. 5,068,338 also discloses that the nitrosamine precursor of the structural formula (F) is a compound (J).
And the compound (K 2) which remains in the mixture and is added as a stabilizer as shown in the following reaction scheme 3.
x) and undergoes a nitrosation reaction to produce N of the following structural formula (B).
It states that -methyl-3- (N-nitroso) aminopropionamide can be formed.

【0016】[0016]

【化9】 Embedded image

【0017】前記米国特許の実施例によると、アミド化
工程後前記構造式(A−2)のN,N′−ジメチル−
3,3′−ジチオジプロピオン中0.5%(5,000
ppm)ないし1.1%(11,000ppm)範囲の
ニトロサミン前駆体が検出されており、また塩素化、濾
過、中和および硝酸塩添加工程を経た最終生成物である
15%水溶液製品中には750ないし1650ppmの
ニトロサミンが検出されている。
According to the embodiment of the above-mentioned US patent, after the amidation step, N, N'-dimethyl- of the above structural formula (A-2) is used.
0.5% in 3,3'-dithiodipropion (5,000
ppm) to 1.1% (11,000 ppm) range of nitrosamine precursors have been detected and 750 in the final product, a 15% aqueous solution, which has undergone chlorination, filtration, neutralization and nitrate addition steps. ˜1650 ppm nitrosamine has been detected.

【0018】したがって、ニトロサミン前駆体がほとん
どない化合物(J )と化合物(K )との混合物を製造す
るために多くの研究が行われてきた。たとえば、米国特
許第4,939,266号、第5,068,338号お
よび第5,312,827号では、化合物(J )および
(K )の混合物製造時に、次の反応図式4に示したよう
にイオン交換、再結晶化および溶媒抽出のような分離技
法を使用するか、またはN−メチルアクリルアミド
(E)親核性スカベンジャーを用いることによって、工
程副産物として生成されるニトロサミンまたはその前駆
体の量を100ppm以下の水準で抑制する方法が開示
されている。
Therefore, much research has been carried out to produce a mixture of compound (J) and compound (K) which is almost free of nitrosamine precursor. For example, in U.S. Pat. Nos. 4,939,266, 5,068,338 and 5,312,827, the following reaction scheme 4 is shown during the preparation of a mixture of compounds (J) and (K). By using separation techniques such as ion exchange, recrystallization and solvent extraction, or by using N-methylacrylamide (E) nucleophilic scavengers, such as nitrosamine or its precursor produced as a process by-product. A method of suppressing the amount at a level of 100 ppm or less is disclosed.

【0019】[0019]

【化10】 Embedded image

【0020】しかし、前記方法は色々な短所がある。す
なわち、再結晶法、溶媒抽出法およびイオン交換法は低
い生成物収率および長い工程時間の問題がある。また、
スカベンジャー法では、前記構造式(A−1)のN−メ
チル−3−メルカプトプロピオンアミドと塩素気体を有
機溶媒中反応させて前記構造式(B)のN−メチル−3
−(N−ニトロソ)アミノプロピオンアミドの生成を抑
制するが、この際前記構造式(A−1)の化合物は、前
記構造式(A−2)のN,N′−ジメチル−3,3′−
ジチオジプロピオンアミドより反応性が大きいため、塩
素気体との反応が激しく進行されて多い反応熱を発生
し、したがって、反応副産物として前記構造式(L )の
4,5−ジクロロ−2−メチル−4−イソチアゾリン−
3−オンが多量に生成する。
However, the above method has various disadvantages. That is, the recrystallization method, the solvent extraction method and the ion exchange method have problems of low product yield and long process time. Also,
In the scavenger method, N-methyl-3-mercaptopropionamide represented by the structural formula (A-1) is reacted with chlorine gas in an organic solvent to produce N-methyl-3 represented by the structural formula (B).
The formation of-(N-nitroso) aminopropionamide is suppressed, and at this time, the compound of the structural formula (A-1) is a compound of the structural formula (A-2) of N, N'-dimethyl-3,3 '. −
Since it is more reactive than dithiodipropionamide, it reacts violently with chlorine gas to generate a large amount of heat of reaction, and therefore, as a by-product of the reaction, 4,5-dichloro-2-methyl- 4-isothiazoline-
A large amount of 3-one is produced.

【0021】したがって、前記米国特許の製造方法を商
業的に適用するには多い制限がある。すなわち、製造時
間および収率の面で経済性が欠けており、また前記構造
式(L )の4,5−ジクロロ−2−メチル−4−イソチ
アゾリン−3−オンが多量に生成し、製造されたイソチ
アゾロン化合物は人体と密接な関係を有する化粧品、医
薬などの分野では人体有害性のため応用が制限されるこ
としかない。
Therefore, there are many limitations to the commercial application of the manufacturing method of said US patent. That is, it is not economical in terms of production time and yield, and a large amount of 4,5-dichloro-2-methyl-4-isothiazolin-3-one of the above structural formula (L) is produced and produced. Also, the application of isothiazolone compounds is limited in the fields of cosmetics, medicine, etc., which are closely related to the human body, because they are harmful to the human body.

【0022】[0022]

【発明が解決しようとする課題】したがって、本発明の
主な目的は、ニトロサミンまたはその前駆体のみでな
く、構造式(L )の4,5−ジクロロ−2−メチル−4
−イソチアゾリン−3−オン不純物がほとんどない、活
性成分として構造式(J )の2−メチル−4−イソチア
ゾリン−3−オンと構造式(K )の5−クロロ−2−メ
チル−4−イソチアゾリン−3−オンの混合物を含む安
定化されたイソチアゾロン組成物を提供することであ
る。
Therefore, the main object of the present invention is not only nitrosamine or its precursor but also 4,5-dichloro-2-methyl-4 of structural formula (L).
-Isothiazolin-3-one 2-Methyl-4-isothiazolin-3-one of structural formula (J) and 5-chloro-2-methyl-4-isothiazolin- of structural formula (K) as active ingredients with few impurities. It is intended to provide a stabilized isothiazolone composition comprising a mixture of 3-ones.

【0023】また、本発明の目的は、しかる混合物を製
造する改善された方法を提供することである。
It is also an object of the present invention to provide an improved method of making such a mixture.

【0024】[0024]

【課題を解決するための手段】本発明は、反応熱を内部
的に焼尽させる混合溶媒系を場合によっては外部冷却手
段と共に用いて、反応系の温度を5ないし20℃範囲で
一定に維持することによって前記混合物に存在する構造
式(L )の化合物を効果的に抑制するのに基づいてい
る。このように製造したイソチアゾロン混合物は、構造
式(J )および(K )の成分を生物学的に有効なモル比
(以下、“生物学的有効量”という)で含みながらも
4,5−ジクロロ−2−メチル−4−イソチアゾリン−
3−オンを実質的にほとんど含有しない。
The present invention employs a mixed solvent system that internally burns out the heat of reaction, optionally with external cooling means to maintain the temperature of the reaction system constant in the range 5 to 20 ° C. By effectively inhibiting the compound of structural formula (L) present in the mixture. The thus-prepared isothiazolone mixture contains 4,5-dichloro while containing the components of structural formulas (J) and (K) in a biologically effective molar ratio (hereinafter referred to as "biologically effective amount"). -2-Methyl-4-isothiazoline-
It contains substantially little 3-one.

【0025】本発明の一つの態様によって、イ)生物学
的有効量の、次の構造式(J )の2−メチル−4−イソ
チアゾリン−3−オンと次の構造式(K )の5−クロロ
−2−メチル−4−イソチアゾリン−3−オンとの混合
物;ロ)有効量の金属硝酸塩安定化剤;およびハ)前記
イ)成分とロ)成分とを溶かすに充分な量の水が含有さ
れており、4,5−ジクロロ−2−メチル−4−イソチ
アゾリン−3−オンがほとんどないことを特徴とする安
定化されたイソチアゾロン組成物が提供される。
According to one embodiment of the present invention, a) a biologically effective amount of 2-methyl-4-isothiazolin-3-one of the following structural formula (J) and 5- of the following structural formula (K) A mixture with chloro-2-methyl-4-isothiazolin-3-one; (b) an effective amount of a metal nitrate stabilizer; and (c) a sufficient amount of water to dissolve the components (a) and (b). And a stabilized isothiazolone composition characterized by being substantially depleted of 4,5-dichloro-2-methyl-4-isothiazolin-3-one.

【0026】[0026]

【化11】 Embedded image

【0027】また、本発明のまた一つの態様によって、
水およびイ)4,5−ジクロロ−2−メチル−4−イソ
チアゾリン−3−オンが100ppm未満に含まれてい
る前記構造式(J )の化合物と前記構造式(K )の化合
物との混合物生物学的有効量;およびロ)水溶性金属硝
酸塩安定化剤有効量を含むことを特徴とする安定化され
たイソチアゾロン水溶液が提供される。
According to another aspect of the present invention,
Water and a) a mixture organism of the compound of the structural formula (J) and the compound of the structural formula (K) containing less than 100 ppm of 4,5-dichloro-2-methyl-4-isothiazolin-3-one A stabilized aqueous solution of isothiazolone is provided which comprises a biologically effective amount; and b) an effective amount of a water-soluble metal nitrate stabilizer.

【0028】なお、本発明はのまた他の態様によって、
次の構造式(A−1)のN−メチル−3−メルカプトプ
ロピオンアミドまたは次の構造式(A−2)のN,N′
−ジメチル−3,3′−ジチオジプロピオンアミドまた
はそれらの混合物と塩素化剤とを、5ないし20℃の反
応温度を維持しながら反応させて、4,5−ジクロロ−
2−メチル−4−イソチアゾリン−3−オンがほとんど
ない、化合物(J )と化合物(K )との混合物を製造す
る方法が提供される。
According to another aspect of the present invention,
N-methyl-3-mercaptopropionamide of the following structural formula (A-1) or N, N ′ of the following structural formula (A-2)
-Dimethyl-3,3'-dithiodipropionamide or a mixture thereof and a chlorinating agent are reacted while maintaining a reaction temperature of 5 to 20 ° C to give 4,5-dichloro-
Provided is a method for producing a mixture of a compound (J) and a compound (K) which is almost free of 2-methyl-4-isothiazolin-3-one.

【0029】[0029]

【化12】 [Chemical 12]

【0030】なお、本発明のまた他の態様によって、構
造式(A−1)の化合物または構造式(A−2)の化合
物またはそれらの混合物と塩素化剤とを各々互いに異な
る有機溶媒に溶かして反応させ、4,5−ジクロロ−2
−メチル−4−イソチアゾリン−3−オンがほとんどな
い、化合物(J )と化合物(K )との混合物を製造する
方法が提供される。
According to still another embodiment of the present invention, the compound of structural formula (A-1) or the compound of structural formula (A-2) or a mixture thereof and the chlorinating agent are dissolved in different organic solvents. To react, 4,5-dichloro-2
Provided is a method for producing a mixture of a compound (J) and a compound (K) which is almost free of -methyl-4-isothiazolin-3-one.

【0031】本発明のまた一つの態様によって、反応後
得られた化合物(J )と化合物(K)との混合物を遠心
分離して前記混合物中のニトロサミンまたはその前駆体
の含量を5ppm未満に調節する段階をさらに含むこと
を特徴とする前記混合物の製造方法が提供される。
According to another embodiment of the present invention, the mixture of compound (J) and compound (K) obtained after the reaction is centrifuged to adjust the content of nitrosamine or its precursor in the mixture to less than 5 ppm. There is provided a method for producing the mixture, further comprising the step of:

【0032】本発明をさらに詳細に説明する。The present invention will be described in more detail.

【0033】本発明者らは、市販イソチアゾロン組成物
またはイソチアゾロン水溶液中には前記構造式(J )お
よび(K )の有効活性成分以外にもニトロサミンまたは
ニトロサミン前駆体は勿論反応副産物として生成される
前記構造式(L )の4,5−ジクロロ−2−メチル−4
−イソチアゾリン−3−オンが検出されていることが分
かった。化合物(L )の含量は極小量であるが、人体に
及ぼす影響を考慮すると必ず除去するか根本的に生成し
ないようにしなければならない。
In addition to the active ingredients of the above structural formulas (J) and (K), in the commercially available isothiazolone composition or aqueous solution of isothiazolone, nitrosamine or a nitrosamine precursor is of course formed as a reaction by-product. Structural formula (L) of 4,5-dichloro-2-methyl-4
It was found that -isothiazolin-3-one was detected. The content of compound (L) is extremely small, but in consideration of the effects on the human body, it must be removed or must not be fundamentally generated.

【0034】一方、不純物として存在するニトロサミン
またはニトロサミン前駆体は出発物質として前記構造式
(A−2)の二硫化物を用いることによって生成され
る。前記構造式(L )の4,5−ジクロロ−2−メチル
−4−イソチアゾリン−3−オンの場合はイソチアゾロ
ン混合物の製造過程で温度条件、塩素化剤の量、使用さ
れた有機溶媒によって生成される副産物である。すなわ
ち、化合物(L )は塩素化工程および環化工程中で化合
物(J )と(K )との混合物を生成して残っている過剰
の内部エネルギーまたは内部熱、過剰量の塩素化剤など
によって過剰反応して生成される。
On the other hand, nitrosamine or a nitrosamine precursor present as an impurity is produced by using the disulfide represented by the structural formula (A-2) as a starting material. In the case of 4,5-dichloro-2-methyl-4-isothiazolin-3-one of the above structural formula (L), it is produced depending on temperature conditions, amount of chlorinating agent and organic solvent used in the process of producing the isothiazolone mixture. It is a by-product. That is, the compound (L) forms a mixture of the compounds (J) and (K) during the chlorination process and the cyclization process, and the excess internal energy or internal heat, the excess amount of the chlorinating agent, etc. It is produced by excessive reaction.

【0035】本発明者らは、イソチアゾロン混合物製造
過程で皮膚刺激物質として知られた前記化合物(L )が
生成し、かかる有害物質の生成は反応系内の温度、塩素
化剤の量および使用する溶媒の組成を特定範囲に維持す
ることによって抑制し得ることが分かった。本発明によ
るイソチアゾロン混合物の製造方法では、出発物質とし
て前記構造式(A−1)のN−メチル−3−メルカプト
プロピオンアミド、前記構造式(A−2)のN,N′−
ジメチル−3,3′−ジチオジプロピオンアミドまたは
これらの混合物が使用される。
The inventors of the present invention produced the aforementioned compound (L) known as a skin irritant during the process of producing the isothiazolone mixture, and the formation of such harmful substances depends on the temperature in the reaction system, the amount of the chlorinating agent and It has been found that this can be suppressed by maintaining the composition of the solvent in a specific range. In the method for producing an isothiazolone mixture according to the present invention, N-methyl-3-mercaptopropionamide of the structural formula (A-1) and N, N'- of the structural formula (A-2) are used as starting materials.
Dimethyl-3,3'-dithiodipropionamide or mixtures thereof are used.

【0036】前記構造式(A−1)または(A−2)の
化合物の塩素化反応は激しい発熱反応であって、反応中
に多い量の反応熱が発生し、これは過剰反応を誘導させ
て目的する化合物(J )および(K )の有効活性成分以
外にも反応副産物として化合物(K )を生成させ得る。
本発明では反応系内の温度を5ないし20℃に維持して
過剰反応による化合物(L )の生成を最大限に阻害して
本発明の目的を達成できる。
The chlorination reaction of the compound of the above structural formula (A-1) or (A-2) is an intense exothermic reaction, and a large amount of heat of reaction is generated during the reaction, which induces an excess reaction. In addition to the target active compounds of the compounds (J) and (K), the compound (K) can be produced as a reaction by-product.
In the present invention, the temperature in the reaction system is maintained at 5 to 20 ° C., and the object of the present invention can be achieved by maximally inhibiting the production of the compound (L) due to the excess reaction.

【0037】一般に発熱反応によって発生する熱は外部
冷却手段によって除去される。しかし、この方法におい
て反応中に発生した内部熱が外部に伝達される前に一定
時間反応混合物内に滞留することになる。したがって、
過剰反応を効果的に防止するためには、反応熱を反応系
内で直接除去するのが好ましい。すなわち、反応系内で
内部手段によって自ら温度が調節されるよう反応システ
ムを設計することが好ましい。
Generally, the heat generated by the exothermic reaction is removed by the external cooling means. However, in this method, the internal heat generated during the reaction stays in the reaction mixture for a certain period of time before being transferred to the outside. Therefore,
In order to effectively prevent the excessive reaction, it is preferable to remove the heat of reaction directly in the reaction system. That is, it is preferable to design the reaction system so that the temperature is controlled by the internal means in the reaction system.

【0038】本発明は、このための一つの好ましい例と
して、複合溶媒システムを選択して反応温度の調節を好
ましく達成される。本発明の複合溶媒システムの一つの
実施態様は、前記構造式(A−1)または(A−2)の
出発物質と塩素化剤各々を互いに異なる有機溶媒に溶か
して、各反応物質の反応性を安定化させると共に塩素化
反応の反応熱を適切に調節することによって、出発物質
の目的する反応を適切に行いながら過剰反応が起こらな
いようにする。好ましくは、前記複合溶媒システムは水
ジャケット、氷水浴およびアセトン−ドライアイス浴の
ような冷却手段と共に用いる。
The present invention, as one preferred example for this, is preferably accomplished by selecting a complex solvent system to control the reaction temperature. One embodiment of the composite solvent system of the present invention is to dissolve the starting material represented by the structural formula (A-1) or (A-2) and the chlorinating agent in different organic solvents to obtain the reactivity of each reactant. Is stabilized and the heat of reaction of the chlorination reaction is adjusted appropriately so that the desired reaction of the starting material is carried out properly while preventing excessive reaction. Preferably, the complex solvent system is used with cooling means such as a water jacket, an ice water bath and an acetone-dry ice bath.

【0039】また、本発明によると、前記複合溶媒の代
わりに通常の単一溶媒下でも外部の冷却手段を通じて反
応系内の温度を調節することもできる。前述した複合溶
媒システムまたは外部冷却手段によって反応系内の温度
を5ないし20℃に維持すると、前記構造式(L )の
4,5−ジクロロ−2−メチル−4−イソチアゾリン−
3−オンの生成を効率的に阻害すると共に反応物の塩素
化反応をよく進行させ得る。
Further, according to the present invention, the temperature in the reaction system can be controlled by an external cooling means even under a normal single solvent instead of the composite solvent. When the temperature in the reaction system is maintained at 5 to 20 ° C. by the above-mentioned complex solvent system or external cooling means, the 4,5-dichloro-2-methyl-4-isothiazoline-containing structure represented by the structural formula (L) is used.
The production of 3-one can be efficiently inhibited and the chlorination reaction of the reaction product can proceed well.

【0040】反応系内の温度が5℃未満であると、反応
速度が過度に遅いので前記構造式(J )の2−メチル−
4−イソチアゾリン−3−オンが前記構造式(K )の5
−クロロ−2−メチル−4−イソチアゾリン−3−オン
より格段に多い生物学的不活性混合物が得られる。ま
た、反応系内の温度が20℃を越えると、過剰反応によ
って前記構造式(L )の4,5−ジクロロ−2−メチル
−4−イソチアゾリン−3−オンが多量に生成する。す
なわち、反応系の温度を5℃ないし20℃範囲に維持し
た時、有害反応物が生成しない前記化合物(J )と化合
物(K )との生物学的に有効な混合物は95モル%以上
の高収率で得られる。
When the temperature in the reaction system is lower than 5 ° C., the reaction rate is excessively slow, and therefore 2-methyl-of the above structural formula (J) is used.
4-isothiazolin-3-one is 5 in the structural formula (K).
A significantly more biologically inert mixture is obtained than -chloro-2-methyl-4-isothiazolin-3-one. When the temperature in the reaction system exceeds 20 ° C., a large amount of 4,5-dichloro-2-methyl-4-isothiazolin-3-one represented by the structural formula (L) is produced due to excess reaction. That is, when the temperature of the reaction system is maintained in the range of 5 ° C to 20 ° C, the biologically effective mixture of the compound (J) and the compound (K), which does not form a harmful reaction product, has a high concentration of 95 mol% or more. Obtained in yield.

【0041】本発明によると、前記のような調節された
反応温度下で塩素化反応させて得られた生成混合物を遠
心分離して反応混合物中に残留するニトロサミンおよび
その前駆体のような不純物を完全に除去することが好ま
しい。そして、反応後反応混合物中に含有している極小
量の他の不純物も遠心分離しながら除去し得る。
According to the present invention, the product mixture obtained by the chlorination reaction under the controlled reaction temperature as described above is centrifuged to remove impurities such as nitrosamine and its precursor remaining in the reaction mixture. It is preferable to completely remove it. After the reaction, a very small amount of other impurities contained in the reaction mixture can be removed by centrifugation.

【0042】前述したように、本発明によると、複合溶
媒システムを用いて前記構造式(L)の4,5−ジクロ
ロ−2−メチル−4−イソチアゾリン−3−オン副産物
の生成を効果的に抑制できる。前記複合溶媒システムの
使用は、構造式(L )の化合物を製造する場合、化合物
(J )および(K )の混合物に比べて高い反応熱と生成
熱を必要とする事実に基づいたものである。
As described above, according to the present invention, the formation of the 4,5-dichloro-2-methyl-4-isothiazolin-3-one by-product of the above structural formula (L) can be effectively performed using a complex solvent system. Can be suppressed. The use of the complex solvent system is based on the fact that a higher heat of reaction and a higher heat of formation are required when producing a compound of structural formula (L) than a mixture of compounds (J) and (K). .

【0043】本発明の複合溶媒システムは次の反応図式
5のように使用される。
The complex solvent system of the present invention is used as shown in Reaction Scheme 5 below.

【0044】[0044]

【化13】 Embedded image

【0045】式中、X2 はCl2 またはSO2 Cl2
あり、S1およびS2はそれぞれ第1有機溶媒と第2有
機溶媒を示す。
In the formula, X 2 is Cl 2 or SO 2 Cl 2 , and S1 and S2 represent a first organic solvent and a second organic solvent, respectively.

【0046】まず、第1有機溶媒に塩化スルホニル(S
2 Cl2 )または塩素気体(Cl2 )などの塩素化剤
を溶かし、この溶液を10ないし60分間撹拌する。次
いで、第2有機溶媒に前記構造式(A−1)の化合物ま
たは前記構造式(A−2)の化合物を溶かす。この際、
選ばれる第1有機溶媒または第2有機溶媒の種類によっ
て塩素化反応時の反応系内温度は変わることができ、選
ばれた有機溶媒の熱容量が大きいほど反応系内の温度は
易しく調節される。ここで、熱容量が大きい有機溶媒と
いうのは単位溶媒分子を気化させるに必要な気化エネル
ギーが大きい溶媒を意味する。
First, sulfonyl chloride (S
A chlorinating agent such as O 2 Cl 2 ) or chlorine gas (Cl 2 ) is dissolved and the solution is stirred for 10 to 60 minutes. Then, the compound of the structural formula (A-1) or the compound of the structural formula (A-2) is dissolved in a second organic solvent. On this occasion,
The temperature in the reaction system during the chlorination reaction can be changed depending on the kind of the first organic solvent or the second organic solvent selected, and the larger the heat capacity of the selected organic solvent, the easier the temperature in the reaction system is adjusted. Here, the organic solvent having a large heat capacity means a solvent having a large vaporization energy required for vaporizing a unit solvent molecule.

【0047】本発明の複合溶媒システムにおいて第1有
機溶媒としては、塩素化剤をよく溶かし、第2有機溶媒
と混合する時混合熱が高くないものを選んで使用する
が、好ましくは、C2 −C10アルキルエーテル、C2
8 アルキルエステル、C5 −C12炭化水素、CH2
2 、CHCX3 、CX4 、CH3 CX3 、CH2 XCH
2 X(この際、Xはハロゲン原子である)およびC6
10芳香族炭化水素である。前記第1有機溶媒と塩素化
剤は1:1ないし20:1の重量比で混合するが、第1
有機溶媒の使用量が下限値より少ないと、塩素化剤を分
散し得る反応熱による衝撃を無くすに充分でなく、上限
値より過度に使用すると、経済的でない。
[0047] As the first organic solvent in the composite solvent system of the present invention, well dissolved chlorinating agent is used to choose what heat of mixing is not high when mixed with a second organic solvent, preferably, C 2 -C 10 alkyl ether, C 2 -
C 8 alkyl esters, C 5 -C 12 hydrocarbons, CH 2 X
2 , CHCX 3 , CX 4 , CH 3 CX 3 , CH 2 XCH
2 X (where X is a halogen atom) and C 6
It is a C 10 aromatic hydrocarbon. The first organic solvent and the chlorinating agent are mixed in a weight ratio of 1: 1 to 20: 1.
If the amount of the organic solvent used is less than the lower limit value, it is not sufficient to eliminate the impact due to the reaction heat that can disperse the chlorinating agent, and if it is used in excess of the upper limit value, it is not economical.

【0048】一方、本発明の複合溶媒システムに使用し
得る第2有機溶媒としては、前記構造式(A−1)の化
合物および/または前記構造式(A−2)の化合物を易
しく溶かし、熱容量が比較的大きくて反応熱を溶媒内へ
相当量分散できることを選んで使用するが、好ましく
は、C4 −C12アルキルエステル、C7 −C14炭化水
素、XCH=CHX、CH2 =CX2 、CX2 =C
2 、CHX=CX2 、C8 −C12芳香族炭化水素およ
びC6 H (6-n ) Xn (この際、nは1ないし5の整数
であり、Xはハロゲン原子である)である。前記第2有
機溶媒と前記構造式(A−1)または(A−2)の出発
物質は一般的に0.2:1ないし20:1の重量比で混
合する。第2有機溶媒の使用量が下限値より少ないと、
出発物質を溶かすに充分でなく、第2有機溶媒の使用量
が上限値を超過すると、過度に多い量の溶媒を使用する
ので経済的でない。
On the other hand, as the second organic solvent that can be used in the composite solvent system of the present invention, the compound of the structural formula (A-1) and / or the compound of the structural formula (A-2) is easily dissolved to obtain a heat capacity. Although but using choose to relatively large heat of reaction can significant amount distributed into the solvent, preferably, C 4 -C 12 alkyl esters, C 7 -C 14 hydrocarbons, XCH = CHX, CH 2 = CX 2 , CX 2 = C
X 2, CHX = CX 2, C 8 -C 12 aromatic hydrocarbons and C 6 H (6-n) X n ( this time, n is 1 to 5 integer, X is a halogen atom) with is there. The second organic solvent and the starting material of the structural formula (A-1) or (A-2) are generally mixed in a weight ratio of 0.2: 1 to 20: 1. When the amount of the second organic solvent used is less than the lower limit value,
If the amount of the second organic solvent used is not sufficient to dissolve the starting material and exceeds the upper limit, an excessively large amount of solvent is used, which is not economical.

【0049】第2有機溶媒と有機溶媒が特定組み合わせ
を成す際その効果は増大する。実験結果によると、好ま
しい複合溶媒システムは前記第1有機溶媒と第2有機溶
媒がそれぞれC4 −C6 アルキルエステルとC6 H (
6-n ) Xn である場合、CHnX (4-n ) とC2 n
(4-n ) (この際、nは1ないし3の整数であり、Xは
ハロゲン原子である)である場合、そしてC6 −C10
香族炭化水素とC4 −C6 アルキルエステルである場合
である。
The effect is enhanced when the second organic solvent and the organic solvent form a specific combination. According to the experimental results, the preferred composite solvent system is such that the first organic solvent and the second organic solvent are C 4 -C 6 alkyl ester and C 6 H (
6-n ) X n , CH n X ( 4-n ) and C 2 H n X
( 4-n ) (where n is an integer of 1 to 3 and X is a halogen atom), and C 6 -C 10 aromatic hydrocarbon and C 4 -C 6 alkyl ester. This is the case.

【0050】本発明で、化合物(J )と化合物(K )の
出発物質と塩素化剤は1:2ないし1:10のモル比で
使用する。塩素化反応に用いられる有機溶媒は反応系へ
再循環させることができ、費用が高い分離工程が必要で
ないので、本発明は製造原価を相当に減らすことができ
るという長所がある。
In the present invention, the starting materials of compound (J) and compound (K) and the chlorinating agent are used in a molar ratio of 1: 2 to 1:10. Since the organic solvent used in the chlorination reaction can be recycled to the reaction system and a costly separation step is not required, the present invention has an advantage that the manufacturing cost can be significantly reduced.

【0051】本発明の方法によって製造されたイソチア
ゾロン混合物中の化合物(J )と化合物(K )は、好ま
しくは1:3ないし1:10のモル比で存在する。
The compound (J) and compound (K) in the isothiazolone mixture prepared by the process of the present invention are preferably present in a molar ratio of 1: 3 to 1:10.

【0052】本発明の組成物に活性成分として用いられ
た前記化合物(J )と(K )の混合物の使用量は、組成
物の1.5ないし15重量%範囲であることが一般的で
あるが、組成物の最終用途によって変わり得る。
The amount of the mixture of the compounds (J) and (K) used as the active ingredient in the composition of the present invention is generally in the range of 1.5 to 15% by weight of the composition. Can vary depending on the end use of the composition.

【0053】本発明の組成物に使用し得る金属硝酸塩安
定化剤としては、水溶性の塩を使用することが好まし
く、たとえば、硝酸ナトリウム、硝酸カリウム、硝酸カ
ルシウム、硝酸マグネシウム、硝酸銅、硝酸鉄(J )、
硝酸鉄(K )、硝酸ニッケル、硝酸亜鉛、硝酸バリウ
ム、硝酸マンガン、硝酸コバルトおよびこれらの混合物
からなる群中で選ばれる。前記金属硝酸塩安定化剤は、
イソチアゾロン混合物を安定化させるに充分な量を加え
るが、一般的に組成物の1ないし30重量%、好ましく
は2ないし20重量%の量で加える。
As the metal nitrate stabilizer that can be used in the composition of the present invention, it is preferable to use a water-soluble salt. For example, sodium nitrate, potassium nitrate, calcium nitrate, magnesium nitrate, copper nitrate, iron nitrate ( J),
It is selected in the group consisting of iron nitrate (K), nickel nitrate, zinc nitrate, barium nitrate, manganese nitrate, cobalt nitrate and mixtures thereof. The metal nitrate stabilizer is
An amount sufficient to stabilize the isothiazolone mixture is added, but generally in an amount of 1 to 30% by weight of the composition, preferably 2 to 20%.

【0054】本発明はまた、生物学的有効量の、前述し
た本発明の製造方法によって製造された化合物(J )お
よび(K )の混合物、有効量の金属硝酸塩安定化剤およ
び前記イソチアゾロン混合物と金属硝酸塩を溶かすに充
分な量の水を含み、ニトロサミンまたはニトロサミン前
駆体、そして前記構造式(L )の4,5−ジクロロ−2
−メチル−4−イソチアゾリン−3−オンがほとんどな
い安定化されたイソチアゾロン組成物または溶液を含
む。
The present invention also comprises a biologically effective amount of a mixture of compounds (J) and (K) prepared by the process of the present invention as described above, an effective amount of a metal nitrate stabilizer and said isothiazolone mixture. Containing nitrosamine or a nitrosamine precursor, and 4,5-dichloro-2 of the structural formula (L) above, containing sufficient amount of water to dissolve the metal nitrate.
-Comprising a stabilized isothiazolone composition or solution that is substantially free of methyl-4-isothiazolin-3-one.

【0055】なお、本発明は、生物学的有効量の、前述
した本発明の製造方法によって製造された化合物(J )
および(K )の混合物を含み、ニトロサミンまたはニト
ロサミン前駆体5ppm未満および前記構造式(L )の
4,5−ジクロロ−2−メチル−4−イソチアゾリン−
3−オン100ppm未満を含有するイソチアゾロン組
成物または水溶液を含む。
The present invention provides a biologically effective amount of the compound (J) produced by the above-mentioned production method of the present invention.
Containing less than 5 ppm of nitrosamine or a nitrosamine precursor and 4,5-dichloro-2-methyl-4-isothiazoline-of the structural formula (L) above.
Includes isothiazolone compositions or aqueous solutions containing less than 100 ppm of 3-one.

【0056】現在市販されているか、または特許として
開示されているイソチアゾロン組成物または水溶液は、
ニトロサミンまたはニトロサミン前駆体を最大限に排除
しようとする努力にもかかわらず、1.5%水溶液で典
型的にニトロサミンまたはニトロサミン前駆体100p
pm以上を含有している。これに反して、本発明の製造
方法によって製造されたイソチアゾロン組成物または溶
液は、塩素化反応後得られた混合物を簡単に遠心分離す
ることによってニトロサミンまたはニトロサミン前駆体
を含有しないか5ppm未満に含有する。
The isothiazolone compositions or aqueous solutions currently commercially available or disclosed as patents are:
Despite efforts to maximally eliminate nitrosamine or nitrosamine precursors, nitrosamine or nitrosamine precursor 100p typically in 1.5% aqueous solution
It contains pm or more. On the contrary, the isothiazolone composition or solution produced by the production method of the present invention contains no nitrosamine or nitrosamine precursor or less than 5 ppm by simply centrifuging the mixture obtained after the chlorination reaction. To do.

【0057】なお、前述した米国特許は皮膚刺激物質と
して知られている化合物(L )の存在に対しては言及し
なかったが、従来の製造方法によって製造されたイソチ
アゾロン組成物または溶液には必然的に化合物(L )を
相当量含有する。しかし、本発明の製造方法によって、
反応系内の温度を調節することによって製造されたイソ
チアゾロン組成物または溶液は化合物(L )を完全に排
除するか100ppm未満に含有する。
Although the above-mentioned US patent does not mention the existence of the compound (L) known as a skin irritant, it is inevitable for the isothiazolone composition or solution prepared by the conventional manufacturing method. Therefore, the compound (L) is contained in a considerable amount. However, according to the manufacturing method of the present invention,
The isothiazolone composition or solution prepared by controlling the temperature in the reaction system completely excludes the compound (L 2) or contains less than 100 ppm.

【0058】本発明を次の実施例に基づいてさらに詳細
に説明するが、本発明がこれによって限られることでは
ない。本願に使用されたすべての単位、%、部などは特
に言及しない限り重量に基づく。
The present invention will be described in more detail based on the following examples, but the present invention is not limited thereto. All units, percentages, parts, etc. used in this application are by weight unless otherwise noted.

【0059】実施例でのサンプルのHPLC(高性能液
体クロマトグラフィー)分析は下記条件下で行った: カラム:μ−ボンダパック(Bondapak)(3.
9x300mm) 移動相:メタノール/水=2/3 流速:1.0ml/分 温度:25℃
HPLC (High Performance Liquid Chromatography) analysis of the samples in the examples was carried out under the following conditions: Column: μ-Bondapak (3.
Mobile phase: Methanol / water = 2/3 Flow rate: 1.0 ml / min Temperature: 25 ° C.

【0060】実施例1 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコにジエチルエーテル310gを入れた
後、0℃で塩化スルフリル(SO2 Cl2 )72g
(0.53モル)を加えた。これに、N−メチル−3−
メルカプトプロピオンアミド(純度99%)30g
(0.25モル)が1,2−ジクロロエチレン120g
に溶けている溶液を−5℃に冷却して2時間にかけて徐
々に加えた。この際、反応系内部の温度は5℃であっ
て、この温度で混合物を2時間撹拌した後、1時間靜置
し、遠心分離して、式(J )の2−メチル−4−イソチ
アゾリン−3−オンと式(K )の5−クロロ−2−メチ
ル−4−イソチアゾリン−3−オンを含有する生成混合
物42.2g(収率83%)を白い結晶として得、これ
をHPLCで分析してその結果を表1に示した。
Example 1 After adding 310 g of diethyl ether to a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, 72 g of sulfuryl chloride (SO 2 Cl 2 ) was added at 0 ° C.
(0.53 mol) was added. To this, N-methyl-3-
Mercaptopropionamide (Purity 99%) 30g
(0.25 mol) is 1,2-dichloroethylene 120 g
The solution dissolved in was cooled to −5 ° C. and gradually added over 2 hours. At this time, the temperature inside the reaction system was 5 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give 2-methyl-4-isothiazoline-formula of the formula (J). 42.2 g (83% yield) of the product mixture containing 3-one and 5-chloro-2-methyl-4-isothiazolin-3-one of formula (K) were obtained as white crystals, which were analyzed by HPLC. The results are shown in Table 1.

【0061】実施例2 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコにn−ヘキサン360gを入れた後、
−5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N−メチル−3−メルカプトプロピオンア
ミド30g(0.25モル)が酢酸n−ヘキシル160
gに溶けている溶液を10℃で2時間にかけて徐々に加
えた。この際、反応系内部の温度は11℃であって、こ
の温度で混合物を2時間撹拌した後、1時間靜置し、遠
心分離して生成混合物47.4g(収率98%)を白い
結晶として得、これをHPLC分析してその結果を表1
に示した。
Example 2 After placing 360 g of n-hexane in a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer,
At −5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. Then, 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide was added to 160 g of n-hexyl acetate.
The solution dissolved in g was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 11 ° C., and the mixture was stirred at this temperature for 2 hours, left standing for 1 hour, and centrifuged to give 47.4 g (yield 98%) of a white mixture as a white crystal. The result was analyzed by HPLC, and the results are shown in Table 1.
It was shown to.

【0062】実施例3 温度計、滴下漏斗および撹拌機が取り付けられた300
ml容量の三口フラスコにクロロホルム78gを入れた
後、−5℃で塩化スルフリル76g(0.56モル)を
加えた。これに、N−メチル−3−メルカプトプロピオ
ンアミド30g(0.25モル)がテトラクロロエチレ
ン6gに溶けている溶液を10℃で2時間にかけて徐々
に加えた。この際、反応系内部の温度は14℃であっ
て、この温度で混合物を2時間撹拌した後、1時間靜置
し、遠心分離して白い結晶としての生成混合物43.6
g(収率89%)を得、これをHPLC分析してその結
果を表1に示した。
Example 3 300 equipped with a thermometer, dropping funnel and stirrer
After putting 78 g of chloroform in a three-necked flask having a capacity of ml, 76 g (0.56 mol) of sulfuryl chloride was added at -5 ° C. To this, a solution of 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide dissolved in 6 g of tetrachloroethylene was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 14 ° C., and the mixture was stirred at this temperature for 2 hours, left standing for 1 hour, and then centrifuged to produce a product mixture as white crystals 43.6.
g (yield 89%) was obtained, which was analyzed by HPLC and the results are shown in Table 1.

【0063】実施例4 温度計、滴下漏斗および撹拌機が取り付けられた3L容
量の三口フラスコにトルエン1500gを入れた後、−
5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N−メチル−3−メルカプトプロピオンア
ミド30g(0.25モル)がn−デカン300gに溶
けている溶液を10℃で2時間にかけて徐々に加えた。
この際、反応系内部の温度は13℃であって、この温度
で混合物を2時間撹拌した後、1時間靜置し、遠心分離
して白い結晶としての生成混合物46.2g(収率98
%)を得、これをHPLC分析してその結果を表1に示
した。
Example 4 1500 g of toluene was placed in a 3 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and then-
At 5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. To this, a solution in which 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide was dissolved in 300 g of n-decane was gradually added at 10 ° C. over 2 hours.
At this time, the temperature inside the reaction system was 13 ° C., and the mixture was stirred at this temperature for 2 hours, left standing for 1 hour, and centrifuged to obtain 46.2 g of a product mixture as white crystals (yield 98
%), Which was analyzed by HPLC and the results are shown in Table 1.

【0064】実施例5 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコに酢酸n−プロピル440gを入れた
後、−5℃で塩化スルフリル82g(0.61モル)を
加えた。これに、N−メチル−3−メルカプトプロピオ
ンアミド30g(0.25モル)がp−キシレン140
gに溶けている溶液を10℃で2時間にかけて徐々に加
えた。この際、反応系内部の温度は12℃であって、こ
の温度で混合物を2時間撹拌した後、1時間靜置し、遠
心分離して白い結晶としての生成混合物46.2g(収
率98%)を得、これをHPLC分析してその結果を表
1に示した。
Example 5 After placing 440 g of n-propyl acetate in a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, 82 g (0.61 mol) of sulfuryl chloride was added at -5 ° C. . To this, 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide was added to p-xylene 140.
The solution dissolved in g was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 12 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to yield 46.2 g of a product mixture as white crystals (yield 98%). ) Was obtained, and this was analyzed by HPLC, and the results are shown in Table 1.

【0065】実施例6 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコにジクロロメタン380gを入れた
後、−5℃で塩化スルフリル70g(0.52モル)を
加えた。これに、N−メチル−3−メルカプトプロピオ
ンアミド30g(0.25モル)が1,1,2−トリク
ロロエタン10gに溶けている溶液を10℃で2時間に
かけて徐々に加えた。この際、反応系内部の温度は16
℃であって、この温度で混合物を2時間撹拌した後、1
時間靜置し、遠心分離して白い結晶としての生成混合物
46.2g(収率98%)を得、これをHPLC分析し
てその結果を表1に示した。
Example 6 380 g of dichloromethane was placed in a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and 70 g (0.52 mol) of sulfuryl chloride was added at -5 ° C. To this, a solution of 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide dissolved in 10 g of 1,1,2-trichloroethane was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system is 16
C. and stirring the mixture at this temperature for 2 hours, then
The mixture was left standing for a while and centrifuged to obtain 46.2 g (yield 98%) of the product mixture as white crystals, which was analyzed by HPLC and the results are shown in Table 1.

【0066】実施例7 温度計、滴下漏斗および撹拌機が取り付けられた3L容
量の三口フラスコに1,2−ジクロロエタン1100g
を入れた後、−5℃で塩化スルフリル76g(0.56
モル)を加えた。これに、N−メチル−3−メルカプト
プロピオンアミド30g(0.25モル)がモノクロロ
ベンゼン600gに溶けている溶液を10℃で2時間に
かけて徐々に加えた。この際、反応系内部の温度は14
℃であって、この温度で混合物を2時間撹拌した後、1
時間靜置し、遠心分離して白い結晶としての生成混合物
46.2g(収率98%)を得、これをHPLC分析し
てその結果を表1に示した。
Example 7 1100 g of 1,2-dichloroethane in a 3 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer.
After the addition of 76 g of sulfuryl chloride at -5 ° C (0.56
Mol) was added. To this, a solution of 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide in 600 g of monochlorobenzene was gradually added over 2 hours at 10 ° C. At this time, the temperature inside the reaction system is 14
C. and stirring the mixture at this temperature for 2 hours, then
The mixture was left standing for a while and centrifuged to obtain 46.2 g (yield 98%) of the product mixture as white crystals, which was analyzed by HPLC and the results are shown in Table 1.

【0067】実施例8 温度計、滴下漏斗および撹拌機が取り付けられた3L容
量の三口フラスコにトルエン1000gを入れた後、−
5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N−メチル−3−メルカプトプロピオンア
ミド30g(0.25モル)が酢酸エチル180gに溶
けている溶液を10℃で2時間にかけて徐々に加えた。
この際、反応系内部の温度は13℃であって、この温度
で混合物を2時間撹拌した後、1時間靜置し、遠心分離
して白い結晶としての生成混合物45.9g(収率98
%)を得、これをHPLC分析してその結果を表1に示
した。
Example 8 After putting 1000 g of toluene in a 3 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, −
At 5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. To this, a solution in which 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide was dissolved in 180 g of ethyl acetate was gradually added at 10 ° C. over 2 hours.
At this time, the temperature inside the reaction system was 13 ° C., and the mixture was stirred at this temperature for 2 hours, left standing for 1 hour, and then centrifuged to obtain 45.9 g of a product mixture as white crystals (yield 98
%), Which was analyzed by HPLC and the results are shown in Table 1.

【0068】実施例9 温度計、滴下漏斗および撹拌機が取り付けられた3L容
量の三口フラスコに酢酸エチル1380gを入れた後、
−5℃で塩化スルフリル76g(0.56モル)を加え
た。ここに、N−メチル−3−メルカプトプロピオンア
ミド30g(0.25モル)がトルエン10gに溶けて
いる溶液を10℃で2時間にかけて徐々に加えた。この
際、反応系内部の温度は12℃であって、この温度で混
合物を2時間撹拌した後、1時間靜置し、遠心分離して
白い結晶としての生成混合物46.2g(収率98%)
を得、これをHPLC分析してその結果を表1に示し
た。
Example 9 1380 g of ethyl acetate was placed in a 3 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and
At −5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. A solution of 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide dissolved in 10 g of toluene was gradually added thereto at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 12 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to yield 46.2 g of a product mixture as white crystals (yield 98%). )
Was obtained and the result was shown in Table 1.

【0069】実施例10 温度計、滴下漏斗および撹拌機が取り付けられた3L容
量の三口フラスコに酢酸ブチル1100gを入れた後、
−5℃で塩化スルホニル76g(0.56モル)を加え
た。これに、N−メチル−3−メルカプトプロピオンア
ミド30g(0.25モル)がモノクロロベンゼン15
gに溶けている溶液を10℃で2時間にかけて徐々に加
えた。この際、反応系内部の温度は15℃であって、こ
の温度で混合物を2時間撹拌した後、1時間靜置し、遠
心分離して白い結晶としての生成混合物46.4g(収
率98%)を得、これをHPLC分析してその結果を表
1に示した。
Example 10 1100 g of butyl acetate was placed in a 3 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer.
At -5 ° C, 76 g (0.56 mol) of sulfonyl chloride was added. To this, 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide was added as monochlorobenzene 15.
The solution dissolved in g was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 15 ° C., and the mixture was stirred at this temperature for 2 hours, left standing for 1 hour, and centrifuged to give 46.4 g of a product mixture as white crystals (yield 98%). ) Was obtained, and this was analyzed by HPLC, and the results are shown in Table 1.

【0070】実施例11 温度計、滴下漏斗および撹拌機が取り付けられた2L容
量の三口フラスコに酢酸ブチル1000gを入れた後、
−5℃で塩化スルホニル76g(0.56モル)を加え
た。これに、N−メチル−3−メルカプトプロピオンア
ミド30g(0.25モル)が1,2−ジクロロベンゼ
ン12gに溶けている溶液を10℃で2時間にかけて徐
々に加えた。この際、反応系内部の温度は14℃であっ
て、この温度で混合物を2時間撹拌した後、1時間靜置
し、遠心分離して白い結晶としての生成混合物46.3
g(収率98%)を得、これをHPLC分析してその結
果を表1に示した。
Example 11 1000 g of butyl acetate was placed in a 2 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer.
At -5 ° C, 76 g (0.56 mol) of sulfonyl chloride was added. To this, a solution of 30 g (0.25 mol) of N-methyl-3-mercaptopropionamide dissolved in 12 g of 1,2-dichlorobenzene was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 14 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to produce a product mixture as white crystals 46.3.
g (yield 98%) was obtained, which was analyzed by HPLC and the results are shown in Table 1.

【0071】実施例12 温度計、滴下漏斗および撹拌機が取り付けられた300
ml容量の三口フラスコにジエチルエーテル72gを入
れた後、0℃で塩化スルフリル72g(0.53モル)
を加えた。これに、N,N′−ジメチル−3,3′−ジ
チオジプロピオンアミド24g(0.10モル)が1,
2−ジクロロエチレン5gに溶けている溶液を−5℃で
2時間にかけて徐々に加えた。この際、反応系内部の温
度は6℃であって、この温度で混合物を2時間撹拌した
後、1時間靜置し、遠心分離して白い結晶としての生成
混合物42.2g(収率83%)を得、これをHPLC
分析してその結果を表1に示した。
Example 12 300 equipped with a thermometer, dropping funnel and stirrer
72 g of diethyl ether was placed in a three-necked flask having a capacity of ml, and then 72 g (0.53 mol) of sulfuryl chloride was added at 0 ° C.
Was added. To this, 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide was added.
A solution of 5 g of 2-dichloroethylene was gradually added at -5 ° C over 2 hours. At this time, the temperature inside the reaction system was 6 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to obtain 42.2 g of a product mixture as white crystals (yield 83%). ) Is obtained and
The results of the analysis are shown in Table 1.

【0072】実施例13 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコにn−ヘキサン300gを入れた後、
−5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N,N′−ジメチル−3,3′−ジチオジ
プロピオンアミド24g(0.10モル)が酢酸n−ヘ
キシル160gに溶けている溶液を10℃で2時間にか
けて徐々に加えた。この際、反応系内部の温度は8℃で
あって、この温度で混合物を2時間撹拌した後、1時間
靜置し遠心分離して白い結晶としての生成混合物47.
4g(収率98%)を得、これをHPLC分析してその
結果を表1に示した。
Example 13 300 g of n-hexane was put into a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer.
At −5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. To this, a solution of 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide in 160 g of n-hexyl acetate was gradually added at 10 ° C over 2 hours. At this time, the temperature inside the reaction system was 8 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to form a mixture 47.
4 g (yield 98%) was obtained, which was analyzed by HPLC and the results are shown in Table 1.

【0073】実施例14 温度計、滴下漏斗および撹拌機が取り付けられた500
ml容量の三口フラスコにクロロホルム200gを入れ
た後、−5℃で塩化スルフリル76g(0.56モル)
を加えた。これに、N,N′−ジメチル−3,3′−ジ
チオジプロピオンアミド24g(0.10モル)がテト
ラクロロエチレン60gに溶けている溶液を10℃で2
時間にかけて徐々に加えた。この際、反応系内部の温度
は19℃であって、この温度で混合物を2時間撹拌した
後、1時間靜置し遠心分離して白い結晶としての生成混
合物43.6g(収率89%)を得、これをHPLC分
析してその結果を表1に示した。
Example 14 500 equipped with a thermometer, dropping funnel and stirrer
After putting 200 g of chloroform into a three-necked flask having a capacity of ml, 76 g (0.56 mol) of sulfuryl chloride at -5 ° C.
Was added. A solution of 24 g (0.10 mol) of N, N′-dimethyl-3,3′-dithiodipropionamide dissolved in 60 g of tetrachloroethylene was added thereto at 2 ° C. at 2 ° C.
Gradually added over time. At this time, the temperature inside the reaction system was 19 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give 43.6 g of a product mixture as white crystals (yield 89%). Was obtained and the result was shown in Table 1.

【0074】実施例15 温度計、滴下漏斗および撹拌機が取り付けられた2L容
量の三口フラスコにトルエン980gを入れた後、−5
℃で塩化スルフリル76g(0.56モル)を加えた。
これに、N,N′−ジメチル−3,3′−ジチオジプロ
ピオンアミド24g(0.10モル)がn−デカン24
gに溶けている溶液を10℃で2時間にかけて徐々に加
えた。この際、反応系内部の温度は17℃であって、こ
の温度で混合物を2時間撹拌した後、1時間靜置し遠心
分離して白い結晶としての生成混合物46.2g(収率
98%)を得、これをHPLC分析してその結果を表1
に示した。
Example 15 980 g of toluene was placed in a 2 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and then -5.
At 0 ° C. 76 g (0.56 mol) of sulfuryl chloride were added.
To this, 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide was added to n-decane 24.
The solution dissolved in g was gradually added at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 17 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give 46.2 g of a product mixture as white crystals (yield 98%). Which was analyzed by HPLC and the results are shown in Table 1.
It was shown to.

【0075】実施例16 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコに酢酸−nプロピル380gを入れた
後、−5℃で塩化スルフリル76g(0.56モル)を
加えた。これに、N,N′−ジメチル−3,3′−ジチ
オジプロピオンアミド24g(0.10モル)がp−キ
シレン150gに溶けている溶液を10℃で2時間にか
けて徐々に加えた。この際、反応系内部の温度は14℃
であって、この温度で混合物を2時間撹拌した後、1時
間靜置し遠心分離して白い結晶としての生成混合物4
6.2g(収率98%)を得、これをHPLC分析して
その結果を表1に示した。
Example 16 To a one-liter three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, 380 g of n-propyl acetate was added, and then 76 g (0.56 mol) of sulfuryl chloride was added at -5 ° C. . To this, a solution of 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide dissolved in 150 g of p-xylene was gradually added at 10 ° C over 2 hours. At this time, the temperature inside the reaction system is 14 ° C.
Then, the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give the product mixture 4 as white crystals.
6.2 g (yield 98%) was obtained, which was analyzed by HPLC and the results are shown in Table 1.

【0076】実施例17 温度計、滴下漏斗および撹拌機が取り付けられた2L容
量の三口フラスコにジクロロメタン1110gを入れた
後、−5℃で塩化スルフリル76g(0.56モル)を
加えた。これに、N,N′−ジメチル−3,3′−ジチ
オジプロピオンアミド24g(0.10モル)が1,
1,2−トリクロロエタン15gに溶けている溶液を1
0℃で2時間にかけて徐々に加えた。この際、反応系内
部の温度は15℃であって、この温度で混合物を2時間
撹拌した後、1時間靜置し遠心分離して白い結晶として
の生成混合物46.2g(収率98%)を得、これをH
PLC分析してその結果を表1に示した。
Example 17 1110 g of dichloromethane was placed in a 2 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and 76 g (0.56 mol) of sulfuryl chloride was added at -5 ° C. To this, 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide was added.
1 solution of 15 g of 1,2-trichloroethane
It was added slowly at 0 ° C. over 2 hours. At this time, the temperature inside the reaction system was 15 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give 46.2 g of a product mixture as white crystals (yield 98%). And get this H
PLC analysis was performed and the results are shown in Table 1.

【0077】実施例18 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコに1,2−ジクロロエタン480gを
入れた後、−5℃で塩化スルフリル76g(0.56モ
ル)を加えた。これに、N,N′−ジメチル−3,3′
−ジチオジプロピオンアミド24g(0.10モル)が
モノクロロベンゼン50gに溶けている溶液を10℃で
2時間にかけて徐々に加えた。この際、反応系内部の温
度は16℃であって、この温度で混合物を2時間撹拌し
た後、1時間靜置し遠心分離して白い結晶としての生成
混合物46.2g(収率98%)を得、これをHPLC
分析してその結果を表1に示した。
Example 18 480 g of 1,2-dichloroethane was placed in a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and 76 g (0.56 mol) of sulfuryl chloride was added at -5 ° C. It was In addition to this, N, N'-dimethyl-3,3 '
A solution of 24 g (0.10 mol) of dithiodipropionamide in 50 g of monochlorobenzene was added slowly at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 16 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give 46.2 g of a product mixture as white crystals (yield 98%). Which is obtained by HPLC
The results of the analysis are shown in Table 1.

【0078】実施例19 温度計、滴下漏斗および撹拌機が取り付けられた2L容
量の三口フラスコにジクロロメタン980gを入れた
後、−5℃で塩化スルホニル76g(0.56モル)を
加えた。これに、N,N′−ジメチル−3,3′−ジチ
オジプロピオンアミド24g(0.10モル)が酢酸エ
チル7gに溶けている溶液を10℃で2時間にかけて徐
々に加えた。この際、反応系内部の温度は14℃であっ
て、この温度で混合物を2時間撹拌した後、1時間靜置
し遠心分離して白い結晶としての生成今後物46.2g
(収率98%)を得、これをHPLC分析してその結果
を表1に示した。
Example 19 980 g of dichloromethane was placed in a 2 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and 76 g (0.56 mol) of sulfonyl chloride was added at -5 ° C. To this, a solution of 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide dissolved in 7 g of ethyl acetate was gradually added at 10 ° C over 2 hours. At this time, the temperature inside the reaction system was 14 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to produce white crystals.
(Yield 98%) was obtained, which was analyzed by HPLC and the results are shown in Table 1.

【0079】実施例20 温度計、滴下漏斗および撹拌機が取り付けられた2L容
量の三口フラスコに酢酸エチル1000gを入れた後、
−5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N,N′−ジメチル−3,3′−ジチオジ
プロピオンアミド24g(0.10モル)がトルエン3
2gに溶けている溶液を10℃で2時間にかけて徐々に
加えた。この際、反応系内部の温度は5℃であって、こ
の温度で混合物を2時間撹拌した後、1時間靜置し遠心
分離して白い結晶としての生成混合物47.4g(収率
98%)を得、これをHPLC分析してその結果を表1
に示した。
Example 20 1000 g of ethyl acetate was placed in a 2 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer,
At −5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. To this, 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide was added to toluene 3
A solution of 2 g was added slowly at 10 ° C. over 2 hours. At this time, the temperature inside the reaction system was 5 ° C., and the mixture was stirred at this temperature for 2 hours, then allowed to stand for 1 hour and centrifuged to give 47.4 g of a product mixture as white crystals (yield 98%). Which was analyzed by HPLC and the results are shown in Table 1.
It was shown to.

【0080】実施例21 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコに酢酸ブチル580gを入れた後、−
5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N,N′−ジメチル−3,3′−ジチオジ
プロピオンアミド24g(0.10モル)がモノクロロ
ベンゼン10gに溶けている溶液を10℃で2時間にか
けて徐々に加えた。この際、反応系内部の温度は11℃
であって、この温度で混合物を2時間撹拌した後、1時
間靜置し遠心分離して白い結晶としての生成今後物4
6.2g(収率98%)を得、これをHPLC分析して
その結果を表1に示した。
Example 21 580 g of butyl acetate was placed in a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and then-
At 5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. To this, a solution of 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide dissolved in 10 g of monochlorobenzene was gradually added at 10 ° C over 2 hours. At this time, the temperature inside the reaction system was 11 ° C.
After stirring the mixture at this temperature for 2 hours, the mixture was left standing for 1 hour and centrifuged to produce white crystals.
6.2 g (yield 98%) was obtained, which was analyzed by HPLC and the results are shown in Table 1.

【0081】実施例22 温度計、滴下漏斗および撹拌機が取り付けられた2L容
量の三口フラスコに酢酸ブチル800gを入れた後、−
5℃で塩化スルフリル76g(0.56モル)を加え
た。これに、N,N′−ジメチル−3,3′−ジチオジ
プロピオンアミド24g(0.10モル)が1,2−ジ
クロロベンゼン8gに溶けている溶液を10℃で2時間
にかけて徐々に加えた。この際、反応系内部の温度は1
5℃であって、この温度で混合物を2時間撹拌した後、
1時間靜置し遠心分離して白い結晶としての生成混合物
45.9g(収率98%)を得、これをHPLC分析し
てその結果を表1に示した。
Example 22 800 g of butyl acetate was placed in a 2 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and then-
At 5 ° C., 76 g (0.56 mol) of sulfuryl chloride was added. To this, a solution of 24 g (0.10 mol) of N, N'-dimethyl-3,3'-dithiodipropionamide dissolved in 8 g of 1,2-dichlorobenzene was gradually added at 10 ° C over 2 hours. . At this time, the temperature inside the reaction system is 1
5 ° C. and after stirring the mixture at this temperature for 2 hours,
The mixture was left standing for 1 hour and centrifuged to obtain 45.9 g (yield 98%) of the product mixture as white crystals, which was analyzed by HPLC and the results are shown in Table 1.

【0082】比較例1 温度計、滴下漏斗および撹拌機が取り付けられた1L容
量の三口フラスコに酢酸エチル500gを入れた後、1
5℃で塩素気体21.3g(0.3モル)を導入した。
これに、N−メチル−3−メルカプトプロピオンアミド
11.9g(0.1モル)を10分画に分けて加えた。
この際、反応系内部の温度は35℃であった。反応溶液
をブフナー(Buchner)漏斗で濾過して沈殿物を
集め、この沈殿物を酢酸エチルで洗浄した後乾燥して白
い結晶13.5g(収率62%)を得、これをHPLC
分析して、その結果を表1に示した。
Comparative Example 1 500 g of ethyl acetate was placed in a 1 L three-necked flask equipped with a thermometer, a dropping funnel and a stirrer, and then 1
21.3 g (0.3 mol) of chlorine gas was introduced at 5 ° C.
To this, 11.9 g (0.1 mol) of N-methyl-3-mercaptopropionamide was added in 10 fractions.
At this time, the temperature inside the reaction system was 35 ° C. The reaction solution was filtered through a Buchner funnel to collect a precipitate, which was washed with ethyl acetate and dried to obtain 13.5 g of white crystals (yield 62%), which was analyzed by HPLC.
Analysis was performed and the results are shown in Table 1.

【0083】比較例2 温度計、滴下漏斗および撹拌機が取り付けられた3L容
量の三口フラスコに酢酸ブチル1280gを入れた後、
−35℃で塩化スルホニル76g(0.56モル)を加
えた。これに、N−メチル−3−メルカプトプロピオン
アミド20g(0.17モル)が酢酸ブチル10gに溶
けている溶液を0℃で8時間にかけて徐々に加えた。こ
の際、反応系内部の温度は25℃であった。この温度で
混合物を8時間撹拌した後、1時間靜置して遠心分離し
て白い結晶38.2g(収率82%)を得、これをHP
LC分析してその結果を表1に示した。
Comparative Example 2 1280 g of butyl acetate was placed in a three-liter three-necked flask equipped with a thermometer, a dropping funnel and a stirrer.
At -35 ° C, 76 g (0.56 mol) of sulfonyl chloride was added. To this, a solution of 20 g (0.17 mol) of N-methyl-3-mercaptopropionamide in 10 g of butyl acetate was gradually added at 0 ° C. over 8 hours. At this time, the temperature inside the reaction system was 25 ° C. The mixture was stirred at this temperature for 8 hours, then allowed to stand for 1 hour and centrifuged to obtain 38.2 g of white crystals (yield 82%).
The results of LC analysis are shown in Table 1.

【0084】[0084]

【表1】 注) 化合物(J ):2−メチル−4−イソチアゾリン−3−
オン 化合物(K ):5−クロロ−2−メチル−4−イソチア
ゾリン−3−オン 化合物(L ):4,5−ジクロロ−2−メチル−4−イ
ソチアゾリン−3−オン
[Table 1] Note) Compound (J): 2-methyl-4-isothiazoline-3-
On Compound (K): 5-chloro-2-methyl-4-isothiazolin-3-one Compound (L): 4,5-dichloro-2-methyl-4-isothiazolin-3-one

【0085】実施例23 撹拌機およびpH測定機が取り付けられた250ml容
量の三口フラスコに水59.7gとMg(NO3 )2 ・
6H2 O38gとを加えて30分間撹拌した。これに、
前記実施例または比較例で製造されたイソチアゾロン混
合物結晶2.1gを入れて30分間撹拌した後、MgO
で溶液のpHを2ないし5の範囲と調整した。得られた
組成物をHPLCで分析して、その結果を次の表2に示
した。
Example 23 In a 250 ml three-necked flask equipped with a stirrer and a pH meter, 59.7 g of water and Mg (NO3) 2.
6H2 O (38 g) was added and the mixture was stirred for 30 minutes. to this,
2.1 g of the crystal of the isothiazolone mixture prepared in the above Example or Comparative Example was added and stirred for 30 minutes, and then MgO was added.
The pH of the solution was adjusted to between 2 and 5 with. The resulting composition was analyzed by HPLC and the results are shown in Table 2 below.

【0086】また、これらの組成物の中の発色可能な有
機および無機不純物の含量を定量的に測定するため色度
(APHA Color)をASTM D 1209に
記載の比色分析法によって測定し、その結果を次の表2
に示した。色度値が高いほど不純物が多く含有されたこ
とを示す。
The chromaticity (APHA Color) was measured by the colorimetric method described in ASTM D 1209 in order to quantitatively measure the content of color-forming organic and inorganic impurities in these compositions. The results are shown in Table 2 below.
It was shown to. The higher the chromaticity value, the more impurities were contained.

【0087】[0087]

【表2】 注) 化合物(J ):2−メチル−4−イソチアゾリン−3−
オン 化合物(K ):5−クロロ−2−メチル−4−イソチア
ゾリン−3−オン 化合物(L ):4,5−ジクロロ−2−メチル−4−イ
ソチアゾリン−3−オン
[Table 2] Note) Compound (J): 2-methyl-4-isothiazoline-3-
On Compound (K): 5-chloro-2-methyl-4-isothiazolin-3-one Compound (L): 4,5-dichloro-2-methyl-4-isothiazolin-3-one

【0088】[0088]

【発明の効果】本発明によって製造された化合物(J )
および(K )の混合物は化合物(J )と化合物(K )を
生理的に有効な混合比、すなわち、1:3ないし10モ
ル比で含むので、多様な製品に殺微生物剤として有用に
使用でき、また人体に有害な4,5−ジクロロ−2−メ
チル−4−イソチアゾリン−3−オンおよびニトロサミ
ン不純物の含量がとても低く色度が50以下であるため
安全に使用できる。
The compound (J) produced by the present invention
The mixture of (K) and (K) contains the compound (J) and the compound (K) in a physiologically effective mixing ratio, that is, in a molar ratio of 1: 3 to 10 and thus can be effectively used as a microbicide in various products. Moreover, the content of 4,5-dichloro-2-methyl-4-isothiazolin-3-one and nitrosamine impurities, which are harmful to the human body, is very low and the chromaticity is 50 or less, so that it can be safely used.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 韓淳宗 大韓民国、ソウル151−050冠岳区奉天洞冠 岳現代アパート123棟1402号 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor, Han Jun Sung, Republic of Korea, Seoul 151-050, Gwanak-dong, Gwanak-dong, Gwanggak-gu, 123 modern apartments No. 1402

Claims (18)

【特許請求の範囲】[Claims] 【請求項1】 イ)生物学的有効量の、次の構造式(J
)の2−メチル−4−イソチアゾリン−3−オンと次
の構造式(K )の5−クロロ−2−メチル−4−イソチ
アゾリン−3−オンとの混合物;ロ)有効量の金属硝酸
塩安定化剤;およびハ)前記イ)成分とロ)成分とを溶
かすに充分な量の水が含有されており、前記(イ)成分
15,000ppmに対して4,5−ジクロロ−2−メ
チル−4−イソチアゾリン−3−オンがほとんどないこ
とを特徴とする安定化されたイソチアゾロン組成物。 【化1】
1. A) A biologically effective amount of the following structural formula (J
) 2-Methyl-4-isothiazolin-3-one and 5-chloro-2-methyl-4-isothiazolin-3-one of the following structural formula (K); b) effective amount of metal nitrate stabilization Agent; and c) Water is contained in an amount sufficient to dissolve the above (a) component and (b) component, and 4,5-dichloro-2-methyl-4 is contained relative to 15,000 ppm of the above (a) component. -A stabilized isothiazolone composition characterized by being substantially free of isothiazolin-3-ones. Embedded image
【請求項2】 前記(イ)成分15,000ppmに対
して4,5−ジクロロ−2−メチル−4−イソチアゾリ
ン−3−オンが20ppm未満に含まれていることを特
徴とする請求項1に記載の組成物。
2. The amount of 4,5-dichloro-2-methyl-4-isothiazolin-3-one contained in less than 20 ppm relative to 15,000 ppm of the component (a). The composition as described.
【請求項3】 前記組成物の色度(APHA Colo
r)が50以下であることを特徴とする請求項1に記載
の組成物。
3. The chromaticity of the composition (APHA Colo
The composition according to claim 1, wherein r) is 50 or less.
【請求項4】 イ)生物学的有効量の、次の構造式(J
)の2−メチル−4−イソチアゾリン−3−オンと次
の構造式(K )の5−クロロ−2−メチル−4−イソチ
アゾリン−3−オンとの混合物;ロ)有効量の金属硝酸
塩安定化剤;およびハ)前記イ)成分とロ)成分とを溶
かすに充分な量の水が含まれており、前記(イ)成分1
5,000ppmに対して4,5−ジクロロ−2−メチ
ル−4−イソチアゾリン−3−オンが100ppm未満
に、そしてニトロサミンまたはその前駆体が5ppm未
満に含まれていることを特徴とする安定化されたイソチ
アゾロン組成物。 【化2】
4. A biologically effective amount of the following structural formula (J
) 2-Methyl-4-isothiazolin-3-one and 5-chloro-2-methyl-4-isothiazolin-3-one of the following structural formula (K); b) effective amount of metal nitrate stabilization An agent; and c) a sufficient amount of water to dissolve the components a) and b) is contained, and the component 1)
Stabilized, characterized in that it contains less than 100 ppm of 4,5-dichloro-2-methyl-4-isothiazolin-3-one and less than 5 ppm of nitrosamine or its precursor relative to 5,000 ppm. Isothiazolone composition. Embedded image
【請求項5】 前記(イ)成分15,000ppmに対
して4,5−ジクロロ−2−メチル−4−イソチアゾリ
ン−3−オンが20ppm未満に含まれていることを特
徴とする請求項4に記載の組成物。
5. The 4,5-dichloro-2-methyl-4-isothiazolin-3-one is contained in an amount of less than 20 ppm with respect to 15,000 ppm of the component (a). The composition as described.
【請求項6】 前記組成物の色度が50以下であること
を特徴とする請求項4に記載の組成物。
6. The composition according to claim 4, wherein the chromaticity of the composition is 50 or less.
【請求項7】 次の構造式(A−1)のN−メチル−3
−メルカプトプロピオンアミドまたは次の構造式(A−
2)のN,N′−ジメチル−3,3′−ジチオジプロピ
オンアミドまたはそれらの混合物と塩素化剤とを、5な
いし20℃の反応温度を維持しながら反応させて、4,
5−ジクロロ−2−メチル−4−イソチアゾリン−3−
オンが100ppm未満に含まれている次の構造式(J
)の2−メチル−4−イソチアゾリン−3−オンと次
の構造式(K )の5−クロロ−2−メチル−4−イソチ
アゾリン−3−オンとの混合物を製造する方法。 【化3】
7. N-methyl-3 having the following structural formula (A-1):
-Mercaptopropionamide or the following structural formula (A-
2) N, N′-dimethyl-3,3′-dithiodipropionamide or a mixture thereof and a chlorinating agent are reacted while maintaining a reaction temperature of 5 to 20 ° C.
5-dichloro-2-methyl-4-isothiazoline-3-
The following structural formula (J containing less than 100 ppm of on
) 2-Methyl-4-isothiazolin-3-one and a 5-chloro-2-methyl-4-isothiazolin-3-one of the following structural formula (K). Embedded image
【請求項8】 前記混合物が20ppm未満の4,5−
ジクロロ−2−メチル−4−イソチアゾリン−3−オン
を含むことを特徴とする請求項7に記載の方法。
8. The mixture containing less than 20 ppm of 4,5-
8. The method of claim 7, comprising dichloro-2-methyl-4-isothiazolin-3-one.
【請求項9】 前記混合物が化合物(J )および化合物
(K )を1:3ないし1:10のモル比で含むことを特
徴とする方法。
9. A process characterized in that the mixture comprises compound (J) and compound (K) in a molar ratio of 1: 3 to 1:10.
【請求項10】 反応後得られた化合物(J )と化合物
(K )との混合物を遠心分離して前記混合物中のニトロ
サミンまたはその前駆体の含量を5ppm未満になるよ
うに調節することをさらに含むことを特徴とする請求項
7、8または9に記載の方法。
10. The method of centrifuging a mixture of the compound (J) and the compound (K) obtained after the reaction to adjust the content of nitrosamine or its precursor in the mixture to be less than 5 ppm. Method according to claim 7, 8 or 9, characterized in that it comprises:
【請求項11】 次の構造式(A−1)のN−メチル−
メルカプトプロピオンアミドまたは次の構造式(A−
2)のN,N′−ジメチル−3,3′−ジチオジプロピ
オンアミドまたはそれらの混合物と塩素化剤とを各々互
いに異なる有機溶媒に溶かして反応させ、4,5−ジク
ロロ−2−メチル−4−イソチアゾリン−3−オンが1
00ppm未満に含まれている次の構造式(J )の2−
メチル−4−イソチアゾリン−3−オンとの次の構造式
(K )の5−クロロ−2−メチル−4−イソチアゾリン
−3−オンとの混合物を製造する方法: 【化4】
11. N-methyl-in the following structural formula (A-1):
Mercaptopropionamide or the following structural formula (A-
2) N, N'-dimethyl-3,3'-dithiodipropionamide or a mixture thereof and a chlorinating agent are dissolved in different organic solvents and reacted to give 4,5-dichloro-2-methyl- 4-isothiazolin-3-one is 1
2-of the following structural formula (J) contained in less than 00 ppm
A process for preparing a mixture of methyl-4-isothiazolin-3-one with 5-chloro-2-methyl-4-isothiazolin-3-one of the following structural formula (K):
【請求項12】 前記混合物が20ppm未満の4,5
−ジクロロ−2−メチル−4−イソチアゾリン−3−オ
ンを含むことを特徴とする請求項11に記載の方法。
12. The mixture contains less than 20 ppm of 4,5
12. The method of claim 11, comprising -dichloro-2-methyl-4-isothiazolin-3-one.
【請求項13】 前記混合物が化合物(J )および化合
物(K )を1:3ないし1:10のモル比で含むことを
特徴とする請求項11に記載の方法。
13. The method according to claim 11, wherein the mixture contains the compound (J) and the compound (K) in a molar ratio of 1: 3 to 1:10.
【請求項14】 反応後得られた化合物(J )と化合物
(K )との混合物を遠心分離して前記混合物中のニトロ
サミンまたはその前駆体の含量を5ppm未満に調節す
ることをさらに含むことを特徴とする請求項11、12
または13に記載の方法。
14. The method further comprising centrifuging the mixture of the compound (J) and the compound (K) obtained after the reaction to adjust the content of nitrosamine or its precursor in the mixture to less than 5 ppm. 13. The method according to claim 11, characterized in that
Or the method described in 13 above.
【請求項15】 前記構造式(A−1)または(A−
2)の化合物を溶かすための有機溶媒が、C4 −C12
ルキルエステル、C7 −C14炭化水素、XCH=CH
X、CH2 =CX2 、CX2 =CX2 、CHX=C
2 、C8 −C12芳香族炭化水素およびC6 H(6-n
n (この際、nは1ないし5の整数で、Xはハロゲン
原子である)からなる群から選ばれることを特徴とする
請求項11に記載の方法。
15. The structural formula (A-1) or (A-
The organic solvent to dissolve the compound of 2), C 4 -C 12 alkyl esters, C 7 -C 14 hydrocarbons, XCH = CH
X, CH 2 = CX 2 , CX 2 = CX 2 , CHX = C
X 2, C 8 -C 12 aromatic hydrocarbons and C 6 H (6-n)
The method according to claim 11, wherein the method is selected from the group consisting of X n (wherein n is an integer of 1 to 5 and X is a halogen atom).
【請求項16】 前記構造式(A−1)または(A−
2)の化合物と有機溶媒とが1:0.2ないし1:20
の重量比で混合されることを特徴とする請求項11また
は15に記載の方法。
16. The structural formula (A-1) or (A-
The compound of 2) and the organic solvent are 1: 0.2 to 1:20.
16. The method according to claim 11 or 15, characterized in that they are mixed in a weight ratio of.
【請求項17】 前記塩素化剤を溶かすための有機溶媒
がC2 −C10アルキルエーテル、C2 −C8 アルキルエ
ステル、C5 −C12炭化水素、CH2 2 、CHC
3 、CX4 、CH3 CX3 、CH2 XCH2 X(この
際、Xはハロゲン原子である)およびC6 −C10芳香族
炭化水素からなる群から選ばれることを特徴とする請求
項11に記載の方法。
17. Organic solvents are C 2 -C 10 alkyl ether for melting of the chlorinating agent, C 2 -C 8 alkyl esters, C 5 -C 12 hydrocarbons, CH 2 X 2, CHC
X 3, CX 4, CH 3 CX 3, CH 2 XCH 2 X claims, characterized in that it is selected from the group consisting of (at this time, X is a halogen atom in a) and C 6 -C 10 aromatic hydrocarbon 11. The method according to 11.
【請求項18】 前記塩素化剤と有機溶媒とが1:1な
いし1:20の重量比で混合されることを特徴とする請
求項11または17に記載の方法。
18. The method according to claim 11, wherein the chlorinating agent and the organic solvent are mixed in a weight ratio of 1: 1 to 1:20.
JP8344180A 1995-12-21 1996-12-24 Method for producing 3-isothiazolone mixture and composition containing the same Expired - Lifetime JP3022365B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1995-53412 1995-12-21
KR19950053412 1995-12-21

Publications (2)

Publication Number Publication Date
JPH09309807A true JPH09309807A (en) 1997-12-02
JP3022365B2 JP3022365B2 (en) 2000-03-21

Family

ID=19442354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8344180A Expired - Lifetime JP3022365B2 (en) 1995-12-21 1996-12-24 Method for producing 3-isothiazolone mixture and composition containing the same

Country Status (4)

Country Link
JP (1) JP3022365B2 (en)
KR (1) KR100212963B1 (en)
DE (1) DE19652531C2 (en)
GB (1) GB2308364B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007230892A (en) * 2006-02-28 2007-09-13 Nippon Soda Co Ltd Isothiazolone-based compound-containing water-soluble preparation and method for stabilizing isothiazolone-based compound
JP2010215663A (en) * 2006-06-02 2010-09-30 Rohm & Haas Co Microbicidal composition
WO2010113857A1 (en) * 2009-03-31 2010-10-07 ナガセケムテックス株式会社 Microbicide

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3732061B2 (en) * 1999-12-27 2006-01-05 株式会社ケミクレア Process for producing 2-alkyl-4-isothiazolin-3-ones
KR100450692B1 (en) * 2002-04-03 2004-10-01 (주)대지화학 Process for isothiazolone compositions
KR100493934B1 (en) * 2002-11-05 2005-06-10 주식회사 한서켐 The manufacturing process for a salt of 2-methyl-4-isothiazoline-3-one

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1189514A (en) * 1982-06-01 1985-06-25 Horst O. Bayer Nitrosamine-free 3-isothiazolones and process
DE3643183A1 (en) * 1986-12-18 1988-06-30 Riedel De Haen Ag METHOD FOR ISOLATING ISOTHIAZOLINE DERIVATIVES
IL97166A (en) * 1991-02-06 1995-10-31 Bromine Compounds Ltd Process for the preparation of 2-methyl-isothiazolin-3-one compounds
WO1992020664A1 (en) * 1991-05-10 1992-11-26 Sunkyong Industries Co., Ltd. A process for preparing 4-isothiazolin-3-one

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007230892A (en) * 2006-02-28 2007-09-13 Nippon Soda Co Ltd Isothiazolone-based compound-containing water-soluble preparation and method for stabilizing isothiazolone-based compound
JP2010215663A (en) * 2006-06-02 2010-09-30 Rohm & Haas Co Microbicidal composition
WO2010113857A1 (en) * 2009-03-31 2010-10-07 ナガセケムテックス株式会社 Microbicide

Also Published As

Publication number Publication date
JP3022365B2 (en) 2000-03-21
GB2308364B (en) 1998-03-25
KR970042527A (en) 1997-07-24
GB9621610D0 (en) 1996-12-04
KR100212963B1 (en) 1999-08-02
GB2308364A (en) 1997-06-25
DE19652531A1 (en) 1997-06-26
DE19652531C2 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
JP2866840B2 (en) Water-soluble 3-isothiazolone composition for biocide
CN104703976B (en) Double (fluoroalkyls) 1,4 benzodiazepine * assimilation compound is used as NOTCH inhibitor
US4939266A (en) Nitrosamine-free 3-isothiazolone
JP3157314B2 (en) Bromate as an inhibitor of nitrosamine formation for nitrate stabilized isothiazolones and process
JPWO2005108370A1 (en) Benzene compounds
CN101790313A (en) chemical compounds
CH663023A5 (en) DERIVATIVES OF FURO- (3,4-C) -PYRIDINE SUBSTITUTED IN POSITION 6, A PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS BASED ON THESE DERIVATIVES.
NO339927B1 (en) Morphine derivative crystals and process for their preparation
JP3022365B2 (en) Method for producing 3-isothiazolone mixture and composition containing the same
JP2003535885A (en) Stable gabapentin with pH in a controlled range
US6376680B1 (en) Process for the preparation of 3-isothiazolone mixture and composition comprising the mixture
EP3717480A1 (en) Method for producing (3s)-3-(4-chlor-3-{[(2s,3r)-2-(4-chlorphenyl)-4,4,4-trifluor-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient
EP0001733A1 (en) 5-Methoxy-psoralene as a new medicament and process for the synthesis
CH628005A5 (en) Process for producing heteropolyanion compounds containing tungsten combined with antimony
LU84091A1 (en) N-CARBAMOYL DERIVATIVES OF ISOTHIAZOLO- (5,4B) PYRIDINE ONE-3, THEIR PREPARATION METHOD AND THEIR USES AS BACTERICIDAL AND FUNGICIDAL AGENTS
JP2018199718A (en) Pharmaceutical formulations containing 3-(4-cinnamyl-1-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and process for their preparation
US5068338A (en) Process for nitrosamine-free sabilized isothiazolones
JPH01190601A (en) Production of clathrate compound
KR100450692B1 (en) Process for isothiazolone compositions
US5420290A (en) Nitrosamine-free 3-isothiazolones and process
EP1250320B1 (en) Novel process for the preparation of alpha-(2,4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
JPH0395103A (en) Production of 3-isothiazolone composition
JP2001270870A (en) Method for producing liquid composition of 3-isothiazolone compound
JPH08176126A (en) New clathrate compound,its production and coating composition containing same
KR19990014934A (en) Salts of pyrrolidinyl methyl indole

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080114

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090114

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090114

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100114

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110114

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120114

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130114

Year of fee payment: 13

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term